User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

5th EMEA forum on cardiovascular risks

5th EMEA forum on cardiovascular risks
  • Cardiometabolic
  • Hypertension
Regional conference by Excemed
Saturday, Nov 26 2016
Marrakech, Morocco

Tags

Cardiovascular risks

Language

English

Registration status
Closed

To register for this event, contact

Meridiano Congress International (Italy)
Project Coordinator: Titty Alvino
T +39 06 88 595 310 -  F +39 06 88595 234
titty.alvino@meridiano.it

Registration fee

110.00€

The registration fee includes:

  • Scientific sessions
  • Coffee break and luncheons
  • Educational materials
  • Certificate of attendance

Target audiences

Cardiologists and internists involved in the prevention and management of patients with cardiovascular risk factors or diseases

Files

Introduction

Access resources by clicking the Outcomes tab or scroll down to the Scientific Programme.

Overview

Hypertension is the primary cause of death and disability worldwide. Despite the availability of several and effective drug classes high blood pressure values still lead to serious cardiovascular pathologies such as ischemic heart disease and heart failure. Thus, the management of essential hypertension is still a challenging issue in clinical practice and a clearly unmet need in the public health system.

The conference will respond to this educational necessity by examining recent evidence in the treatment of hypertension with a specific focus on the “aggressive” new blood pressure targets indicated by the results of the Systolic Blood Pressure Intervention Trial (SPRINT) study. Discussion will also focus on the different incidence and gravity of hypertension in the black population as well as the hot topic of heart rate, which, in combination with high blood pressure, can increase cardiovascular risk. Treating the main hypertension–related clinical conditions, including acute coronary syndrome and heart failure, will also be addressed.

Learning objectives

  • Define blood pressure targets in hypertensive patients and the advantages/disadvantages for an eventual aggressive treatment
  • Discuss the incidence, physiopathology and clinical consequences of hypertension in the black population
  • Address the relevance of combination treatment in hypertension and the clinical indications for new fixed-dose combination beta-blocker/calcium antagonist
  • Discuss the state of the art in the treatment of hypertensive patients with coronary artery disease
  • Manage the complexity of the relationship between hypertension and heart failure with particular attention to the possible benefits of pharmacological treatments.

Accreditation details

An application will be made to the EBAC for CME accreditation of the "5th EMEA forum on cardiovascular risks" to be held on 26 November 2016 in Marrakech, Morocco.

Scientific programme

Saturday, 26 November 2016

 

8.45                       Welcome and introduction

                               G. Mancia (Italy)

               

9.00       KNL        Hypertension guidelines after SPRINT Video lecture

                              G. Mancia (Italy)

 

9.30      

L1           Managing hypertension in a black population

                              B. M. Egan (USA)

 

9.50      

L2           Combination treatment in hypertension: what are the alternatives to RAS-blockers?

                              A. Coca (Spain)

 

10.10                    Panel discussion

 

10.40                    Coffee break

 

11.00    

L3           Management of stable chronic angina Video lecture

                             L. Poulimenos (Greece)

 

11.20    

L4           Heart failure treatment: from guidelines to clinical practice Video lecture

                               E. Erdmann (Germany)

 

11.40                     Panel discussion

12.00                     Interactive workshops with clinical cases and voting system (with rotation)

From guidelines to clinical practice

 

                W1         The role of beta-blockers in hypertensive patients

                                J. Polónia (Portugal)

 

                W2         How to optimize treatment in patients with heart failure

                               S. Taddei (Italy)

 

13.30                     Take home messages from clinical cases (in plenary room)

                               S. Taddei (Italy) and J. Polónia (Portugal)

 

14.00                     Closing remarks and end of the conference

                                G. Mancia (Italy)

Closing lunch

CME provider

EXCEMED - Excellence in Medical Education

 

Programme and Relations Manager: Flaminia Masprone
T +39 06 420413 206 - F +39 06 420413 677
flaminia.masprone@excemed.org

Chair(s)

Giuseppe Mancia

Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy
Speakers

Erland Erdmann

Department of Cardiology
University of Köln
Köln, Germany

Giuseppe Mancia

Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy

Stefano Taddei

Department of Clinical and Experimental Medicine
Hypertension Unit
University of Pisa
Pisa, Italy
Slide kit
Stefano Taddei
Cardiometabolic
Slide kit
Jorge Polónia
Cardiometabolic
Slide kit
Erland Erdmann
Cardiometabolic
Slide kit
Leonidas Poulimenos
Cardiometabolic
Slide kit
Giuseppe Mancia
Cardiometabolic